RT Journal Article
SR Electronic
T1 Towards personalized rTMS in tinnitus: reliability of individualized stimulation protocols in behavioral and electrophysiological responses
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.11.21249600
DO 10.1101/2021.01.11.21249600
A1 Schoisswohl, Stefan
A1 Langguth, Berthold
A1 Hebel, Tobias
A1 Abdelnaim, Mohamed A.
A1 Volberg, Gregor
A1 Schecklmann, Martin
YR 2021
UL http://medrxiv.org/content/early/2021/01/13/2021.01.11.21249600.abstract
AB Background Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation tool potentially modulating pathological brain activity. Its clinical effectiveness is hampered by varying results and characterized by inter-individual variability in treatment responses. RTMS individualization might constitute a useful strategy to overcome this variability. A precondition for this approach would be that repeatedly applied protocols result in reliable effects. The condition tinnitus provides the advantage of immediate behavioral consequences (tinnitus loudness changes) after interventions and thus offers an excellent model to exemplify TMS personalization.Objective The aim was to investigate the test-retest reliability of short rTMS stimulations in modifying tinnitus loudness and oscillatory brain activity as well as to examine the feasibility of rTMS individualization in tinnitus.Methods Three short verum (1Hz, 10Hz, 20Hz; 200 pulses) and one sham (0.1Hz; 20 pulses) rTMS protocol were administered on two different days in 22 tinnitus patients. Before and after each protocol, oscillatory brain activity was recorded with electroencephalography (EEG) together with behavioral tinnitus loudness ratings. Stimulation responders were identified via consistent and sham-superior behavioral or electrophysiological responses according to the prevalent neurophysiological models for tinnitus.Results It was feasible to identify individualized rTMS protocols featuring reliable tinnitus loudness changes (55% responder), alpha increases (91% responder) and gamma decreases (100% responder) respectively. Contrary, test-retest correlation analyses per protocol on a group-level were not significant neither for behavioral nor for electrophysiological effects. No associations between behavioral and EEG responses were given.Conclusion RTMS individualization via behavioral and electrophysiological data in tinnitus can be considered as a feasible approach to overcome low reliability on group-level. The present results open the discussion favoring personalization utilizing neurophysiological markers rather than behavioral responses. These insights are not only useful for the rTMS treatment of tinnitus but also for neuromodulation interventions in other pathologies as our results suggest that the individualization of stimulation protocols is feasible despite absent group-level reliability.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe want to thank Nexstim Plc. for providing the electric-field guided neuronavigation rTMS system to perform this feasibility trial. The project was conducted as part of the European School for Interdisciplinary Tinnitus Research (ESIT) and was partially funded by the European Union's Horizon 2020 Marie Sklodowska-Curie Actions (grant agreement number 722046, ESIT project) and the European Union's Horizon 2020 Framework Programme (grant agreement number 848261, UNITI project).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethics committee of the University of Regensburg, Germany (ethical approval number: 17-820-101)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated for this study are available on request to the corresponding author.